25682-001Level 3
SOLIRIS (ECULIZUMAB)
**Product type:** Human Prescription Drug
**Active ingredient:** ECULIZUMAB
**Strength:** 300 mg/30mL
**Dosage form:** Injection, Solution, Concentrate
**Route:** Intravenous
**Labeler:** Alexion Pharmaceuticals Inc.
**Marketing category:** BLA (BLA125166)
**Pharmacologic class:** Complement Inhibitor [EPC], Complement Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/25682-001Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.